NCT06592326 2024-09-199MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial CancerMabwell (Shanghai) Bioscience Co., Ltd.Phase 3 Recruiting460 enrolled